4.32
price down icon3.16%   -0.11
 
loading
Precedente Chiudi:
$4.43
Aprire:
$4.26
Volume 24 ore:
71,654
Relative Volume:
0.11
Capitalizzazione di mercato:
$469.02M
Reddito:
-
Utile/perdita netta:
$-299.80M
Rapporto P/E:
-0.3564
EPS:
-12.1221
Flusso di cassa netto:
$-217.49M
1 W Prestazione:
-16.86%
1M Prestazione:
-30.58%
6M Prestazione:
-0.92%
1 anno Prestazione:
-50.23%
Intervallo 1D:
Value
$4.24
$4.44
Intervallo di 1 settimana:
Value
$4.24
$5.19
Portata 52W:
Value
$3.36
$8.885

Acelyrin Inc Stock (SLRN) Company Profile

Name
Nome
Acelyrin Inc
Name
Telefono
805-871-4300
Name
Indirizzo
4149 LIBERTY CANYON RD., AGOURA HILLS
Name
Dipendente
130
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-13
Name
Ultimi documenti SEC
Name
SLRN's Discussions on Twitter

Confronta SLRN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
SLRN 4.335 469.02M 0 -299.80M -217.49M -12.12
VRTX 447.18 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.71 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.39 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.84 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.36 24.49B 3.30B -501.07M 1.03B 11.54

Acelyrin Inc Stock (SLRN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-14 Downgrade H.C. Wainwright Buy → Neutral
2024-07-08 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-12-13 Iniziato Wells Fargo Equal Weight
2023-12-08 Iniziato Citigroup Neutral
2023-09-13 Downgrade Morgan Stanley Overweight → Equal-Weight
2023-09-05 Iniziato H.C. Wainwright Buy
2023-05-30 Iniziato Jefferies Buy
2023-05-30 Iniziato Morgan Stanley Overweight
2023-05-30 Iniziato Piper Sandler Overweight
2023-05-30 Iniziato TD Cowen Outperform
Mostra tutto

Acelyrin Inc Borsa (SLRN) Ultime notizie

pulisher
Nov 18, 2024

HC Wainwright Issues Positive Estimate for Acelyrin Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

TD Cowen maintains Buy rating on Acelyrin shares By Investing.com - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

Acelyrin discloses ValenzaBio acquisition financials - Investing.com India

Nov 15, 2024
pulisher
Nov 14, 2024

TD Cowen maintains Buy rating on Acelyrin shares - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

T. Rowe Price Investment Management, Inc. Reduces Stake in Acely - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Earnings call: Acelyrin focuses on TED treatment, eyes Phase 3 trials - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Acelyrin Inc (SLRN) Q3 2024 Earnings Call Highlights: Strategic Pipeline Refocus and Financial ... By GuruFocus - Investing.com Canada

Nov 14, 2024
pulisher
Nov 13, 2024

ACELYRIN, INC. Advances Key Drug Developments - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

ACELYRIN Reports $562M Cash Position, Advances Key Clinical Trials Amid Pipeline Focus | SLRN Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 08, 2024

(SLRN) Investment Analysis and Advice - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 07, 2024

Acelyrin (SLRN) Set to Announce Earnings on Wednesday - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

ACELYRIN, INC. to Report Third Quarter 2024 Financial Results and Corporate Update on November 13, 2024 - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

ACELYRIN Sets Q3 2024 Earnings Call: Immunology Pipeline Updates Coming Nov 13 | SLRN Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Acelyrin Inc Shares - GuruFocus.com

Nov 05, 2024
pulisher
Oct 30, 2024

10 Best IPO Stocks To Buy Heading into 2025 - Insider Monkey

Oct 30, 2024
pulisher
Oct 28, 2024

(SLRN) Proactive Strategies - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 28, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Receives $11.17 Consensus PT from Analysts - MarketBeat

Oct 28, 2024
pulisher
Oct 27, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Short Interest Update - MarketBeat

Oct 27, 2024
pulisher
Oct 20, 2024

The Manufacturers Life Insurance Company Acquires 4,163 Shares of Acelyrin, Inc. (NASDAQ:SLRN) - Defense World

Oct 20, 2024
pulisher
Oct 18, 2024

Acelyrin (NASDAQ:SLRN) Trading Down 6.9%What's Next? - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

(SLRN) Trading Advice - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 17, 2024

Acelyrin (NASDAQ:SLRN) Trading 4.8% Higher on Analyst Upgrade - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

SLRNACELYRIN, INC. Latest Stock News & Market Updates - StockTitan

Oct 17, 2024
pulisher
Oct 16, 2024

Wells Fargo & Company Boosts Acelyrin (NASDAQ:SLRN) Price Target to $15.00 - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease - The Manila Times

Oct 16, 2024
pulisher
Oct 14, 2024

Did Acelyrin Inc (SLRN) perform well in the last session? - US Post News

Oct 14, 2024
pulisher
Oct 11, 2024

Acelyrin (NASDAQ:SLRN) Stock Price Down 2.4%Should You Sell? - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Acelyrin Inc (SLRN) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Oct 11, 2024
pulisher
Oct 10, 2024

Acelyrin (NASDAQ:SLRN) Shares Up 5.9%Still a Buy? - MarketBeat

Oct 10, 2024
pulisher
Oct 06, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Oct 06, 2024
pulisher
Oct 05, 2024

Millennium Management LLC Has $20.47 Million Stake in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Oct 05, 2024
pulisher
Oct 04, 2024

Renaissance Technologies LLC Has $1.75 Million Stake in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

160,167 Shares in Acelyrin, Inc. (NASDAQ:SLRN) Bought by Susquehanna Fundamental Investments LLC - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Susquehanna Fundamental Investments LLC Takes Position in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Recent Insider Activity Suggests Potential Gains for Acelyrin Inc (SLRN) - Knox Daily

Oct 02, 2024
pulisher
Sep 29, 2024

Almitas Capital LLC Buys New Position in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Sep 29, 2024
pulisher
Sep 25, 2024

Piper Sandler maintains Overweight rating on Acelyrin shares - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Piper Sandler maintains Overweight rating on Acelyrin shares By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 25, 2024

Acelyrin Inc [SLRN] Director makes an insider sale of 1 shares worth $7.0. - Knox Daily

Sep 25, 2024
pulisher
Sep 25, 2024

Top investors say Acelyrin Inc (SLRN) ticks everything they need - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

Acelyrin Insider Sellers Miss The Bus As Stock Jumps 12% - Simply Wall St

Sep 25, 2024
pulisher
Sep 24, 2024

Can Acelyrin Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle

Sep 24, 2024
pulisher
Sep 23, 2024

Acelyrin (NASDAQ:SLRN) Shares Down 5.4% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

How did Acelyrin Inc (SLRN) fare last session? - US Post News

Sep 23, 2024
pulisher
Sep 20, 2024

Acelyrin: Straight Move To Phase 3 TED Studies Makes It Must Watch (NASDAQ:SLRN) - Seeking Alpha

Sep 20, 2024
pulisher
Sep 19, 2024

Acelyrin (NASDAQ:SLRN) Shares Gap Up to $4.60 - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Acelyrin stock spikes on upcoming presentation (NASDAQ:SLRN) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 19, 2024

Acelyrin announces positive results from Phase 3 trial of izokibep - TipRanks

Sep 19, 2024

Acelyrin Inc Azioni (SLRN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Acelyrin Inc Azioni (SLRN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Lin Shao-Lee
Chief Executive Officer
Apr 01 '24
Sale
6.63
9,961
66,024
1,577,374
Lin Shao-Lee
Chief Executive Officer
Feb 20 '24
Sale
7.60
15,701
119,403
1,587,335
Lin Shao-Lee
Chief Executive Officer
Jan 02 '24
Sale
7.41
10,691
79,188
1,603,036
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):